Article
Multiple lysine mutations in the C-terminus of p53 make it resistant to degradation mediated by MDM2 but not by human papillomavirus E6 and induce growth inhibition in MDM2-overexpressing cells.
Oncogene - 11 Apr 2002
Nakamura Seiichi, Roth Jack A, Mukhopadhyay Tapas
Abstract excerpt
We have recently shown that lysine mutations in p53's putative C-terminal acetylation sites result in increased stability and cytoplasmic distribution of the p53 protein in a human lung cancer cell line. In the present study, we showed that when lysine residues 372, 373, 381, and 382 of p53 were substituted with alanine, the resulting A4 protein was resistant to MDM2-mediated proteosomal degradation but was...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
